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Abstract
Endothelium derived signaling mechanisms play an important role in regulating
vascular tone and endothelial dysfunction is often found in hypertension.
Endothelium-derived hyperpolarization (EDH) plays a significant role in smaller
renal arteries and arterioles, but its significance in vivo in hypertension is unre-
solved. The aim of this study was to characterize the EDH-induced renal vasodi-
lation in normotensive and hypertensive rats during acute intrarenal infusion of
ACh. Our hypothesis was that the increased renal vascular resistance (RVR)
found early in hypertension would significantly correlate with reduced EDH-in-
duced vasodilation. In isoflurane-anesthetized 12-week-old normo- and hyper-
tensive rats blood pressure and renal blood flow (RBF) was measured
continuously. RBF responses to acute intrarenal ACh infusions were measured
before and after inhibition of NO and prostacyclin. Additionally, RVR was
decreased or increased using inhibition or activation of adrenergic receptors or
by use of papaverine and angiotensin II. Intrarenal infusion of ACh elicited a lar-
ger increase in RBF in hypertensive rats compared to normotensive rats suggest-
ing that endothelial dysfunction is not present in 12-week-old hypertensive rats.
The EDH-induced renal vasodilation (after inhibition of NO and prostacyclin)
was similar between normo- and hypertensive rats. Reducing RVR by inhibition
of a1-adrenergic receptors significantly increased the renal EDH response in
hypertensive rats, but a similar increase was found after activating a-adrenergic
receptors using norepinephrine. The results show that renal EDH is present and
functional in 12-week-old normo- and hypertensive rats. Interestingly, both
activation and inactivation of a1-adrenergic receptors elicited an increase in the
renal EDH-induced vasodilation.
Introduction
Arterial hypertension is associated with increased periph-
eral resistance and is a major risk factor for cardiovascu-
lar complications. There is strong evidence from human
and animal studies for a primary role of altered renal
control of Na+ and water excretion in the pathogenesis
of hypertension (Guyton et al., 1972). Renal Na+ and
water excretion is determined by the balance between
renal glomerular filtration rate (GFR) and reabsorption
of Na+ and water. Control of the renal microcirculation
is therefore central for the control of arterial blood pres-
sure.
Endothelium derived signaling mechanisms play an
important role in the regulation of vascular tone and
endothelial dysfunction is often found in hypertension
(Mattei et al., 1997; Cupisti et al., 2000). Endothelial dys-
function may be due to decreased bioavailability of nitric
oxide (NO), possibly caused by increased oxidative stress
seen in hypertension (Touyz, 2004). NO and prostacyclin
are main contributors to endothelium-dependent vasodi-
lation. Endothelium-dependent dilation remaining after
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inhibition of NO and prostaglandin production is by defi-
nition caused by endothelium-derived hyperpolarization
(EDH) (Mombouli and Vanhoutte, 1997). The nature of
EDH is still not clarified and the relative importance of
EDH and other endothelial vasodilatory mechanisms may
differ depending on vascular bed, species, age, physiologi-
cal, and pathophysiological conditions.
Studies on renal EDH in hypertension have generated
conflicting results. In afferent arterioles from 13 to 16-
week-old spontaneously hypertensive rats (SHR) inhibi-
tion of NO production reduced afferent arteriolar diame-
ter more compared to arterioles from normotensive rats
whereas renal EDH was significantly reduced suggesting a
high NO production and low contribution from EDH in
young SHR (Ito and Carretero, 1992; Hayashi et al.,
1999). However, in renal arteries from 8-week-old SHR,
EDH-induced vasodilation is stronger (Bussemaker et al.,
2003) but decreases with increasing age (Bussemaker
et al., 2003; Michel et al., 2008). Possibly the difference in
vessel size and function contributes to this discrepancy as
EDH has been shown to be more prevalent in smaller
resistance vessels (Shimokawa et al., 1996; Boettcher and
Wit, 2011).
In vascular smooth muscle cells (VSMC) from afferent
arterioles from normotensive rats a membrane potential
(Vm) of 40 mV has been reported (Loutzenhiser et al.,
1997). Vm has not been measured in similar VSMC from
hypertensive animals but in renal artery VSMC from 8-
week-old SHR Vm is 45 mV. At increasing age and
blood pressure the Vm depolarized to 35 mV at
22 months (Bussemaker et al., 2003). In interlobar VSMC
from 15-week-old normo- and hypertensive rats Vm is
50 mV and 32 mV respectively (Martens and Gel-
band, 1996). It seems plausible that at a more depolarized
Vm a stronger hyperpolarizing stimulus is required to
attain the same degree of vasodilation.
Increased vascular tone induced by increased pressure
or increased agonist addition has been shown to signifi-
cantly reduce EDH-induced vasodilation (Gschwend
et al., 2003; Yarova et al., 2013). A suggested mechanism
is the release of K+ from VSMC (Richards et al., 2001).
When NE is added and VSMC depolarize the following
Ca2+ influx activates BKCa channels and K
+ efflux
increases to dampen the vasoconstriction. This increase in
extracellular K+ saturates KIR channels and Na
+/K+-
ATPases on the VSMC. A following release of endothelial
derived K+ during EDH will now elicit a smaller EDH-in-
duced vasodilation.
Increased renal sympathetic nerve activity has been
linked to hypertension. This is illustrated by the observa-
tions that renal denervation lowers hypertension both in
animals (Lee and Walsh, 1983; Gattone et al., 1984) and
humans (Chen and Upadhyay, 2017). Increased renal
sympathetic nerve activity leads to constriction of renal
resistance vessels. In 12-week-old SHR renal denervation
not only reduced blood pressure but also led to increased
afferent arteriolar diameter after 2 weeks (Gattone et al.,
1984). Renal vasoconstriction in response to the sympa-
thetic neurotransmitter norepinephrine (NE) is to a large
extent dependent on activation of voltage operated Ca2+
channels (VOCC) (Salomonsson and Arendshorst, 1999).
This indicates that NE induces a depolarization in renal
VSMC similar to what is found in other vascular beds. It
has been shown that NE induces a larger depolarization
and a stronger contraction in VSMC from tail arteries
from SHR compared to WKY (Hermsmeyer, 1976). Also,
mesenteric VSMC from SHR have a higher intracellular
Ca2+ concentration (Touyz and Schiffrin, 1997) and a
higher expression of L-type VOCC (Pratt et al., 2002)
compared to normotensive rats. In afferent arterioles, NE
increased the Ca2+ sensitivity to increase Ang II-induced
vasoconstriction (Lai et al., 2009). Thus, a connection
between increased sympathetic activity and increased
VSMC contractility seems likely.
The aim of the present study was to investigate the
EDH-induced vasodilation in the kidney and the potential
physiological role thereof in the renal microcirculation in
hypertensive and normotensive rats in vivo. The main
hypothesis was that the increased renal vascular resistance
(RVR) found in SHR would reduce the EDH response
in vivo. The increased RVR could be caused by the
increase in Vm and/or intracellular Ca
2+ found in VSMC
from SHR. The increased RVR could be induced by
increasing blood pressure or increased sympathetic activ-
ity. Thus, the magnitude of the renal EDH response may
change in hypertensive rats with age and development of
hypertension as a consequence of the increased blood
pressure per se or as an effect of increased activation of
adrenergic receptors caused by increased renal sympa-
thetic activity seen in hypertension (Lundin et al., 1984).
Experiments were performed in normotensive C57BL/6
mice, Sprague–Dawley (SD) rats, and SHR. SD rats were
chosen because the WKY, normally used as control for
SHR, has been shown to have abnormal Ca2+ sensitivity
and connexin expression in resistance vessels compared to
normotensive outbred Wistar and SD rats (Mulvany and
Korsgaard, 1983; Braunstein et al., 2009). In isolated renal
interlobar arteries from normotensive mice and rats, we
tested if increased preconstriction (mimicking increased
RVR) in general would affect renal EDH-induced vasodi-
lation. In anesthetized SD and SHR we examined the
effect of intrarenal bolus infusion of ACh on renal blood
flow (RBF). The infusions were done before and after
treatment with the NO synthase inhibitor N(x)-nitro-L-
arginine methyl ester (L-NAME) and the cyclooxygenase
inhibitor indomethacin. Thereafter we assessed the effect
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of reducing renal vascular resistance using prazosin (an
a1-adrenergic receptor antagonist reducing activation of
adrenergic receptors) or papaverine (a phosphodiesterase
inhibitor). Increases in renal vascular resistance were per-
formed using NE (to increase activation of adrenergic
receptors) or angiotensin II.
Methods
The in vivo experiments were performed on 27 normoten-
sive Sprague–Dawley (SD) rats and 30 SHR weighing
298  5 g and 292  4 g, respectively (app. 12 weeks
old). The animals were purchased from Taconic (Denmark
and USA). All experiments were approved by the Danish
National Animal Experiments Inspectorate and conform
to the European Convention for the Protection of Verte-
brate Animals used for Experimental and other Scientific
Purposes. The in vitro studies were performed on 10 SD
rats and four C57/Bl6 mice weighing 303  4 g and
29  1 g, respectively. These animals were also purchased
from Taconic (Denmark). Animals were held in the ani-
mal facility at University of Copenhagen with a 12:12 h
light/dark cycle. Animals had free access to drinking water
and standard diet. All procedures involving animals were
in accordance with the ethical standards of the University
of Copenhagen at which the studies were conducted.
EDH in isolated renal interlobar arteries
Rats were anaesthetized with 5% isofluran delivered in
35% oxygen and 65% nitrogen and euthanized with
spinal cord dislocation. Mice were euthanized with spinal
cord dislocation. The kidneys were excised and bathed in
cold dissection buffer (in mmol/L: NaCl 135, KCl 5,
MgSO47H2O 1, HEPES 10, glucose 5, CaCl2 1 and albu-
min 5 g/L, pH 7.4). Renal interlobar arteries were dis-
sected and cut into 2-mm pieces. The arteries were
threaded onto two stainless steel wires (Ø40 µm) and
transferred to a preheated (37°C) myograph chamber
(Danish Myograph Technology A/S, Aarhus, Denmark)
containing a physiological saline solution (PSS in mmol/
L: NaCl 130, NaHCO3 14.9, KCl 4.7, MgSO47H2O 1.17,
KH2PO4 1.18, glucose 5.5, CaCl2 1.6, EDTA 0.026) aer-
ated with 95% O2 and 5% CO2, resulting in a pH of 7.4.
The vessels were normalized to a tension equivalent to 0.9
times the tension found at a transmural pressure equiva-
lent to 100 mmHg according to a previous protocol
(Mulvany and Halpern, 1977).
Myograph protocol
All protocols were initiated with two exposures to PSS
containing 60-mmol/L K+ and 10-µmol/L norepinephrine
(NE) serving as viability test and reference contractions.
Vessels developing a tension <1 mN (rats) or <0.75 mN
(mice) were discarded. The vessels were incubated for
30 min with PSS containing L-NAME (300 µmol/L) and
indomethacin (3 µmol/L) to inhibit production of NO
and PGI2. The vessels were then preconstricted with
increasing concentrations of NE (10–500 nmol/L; rats:
n = 7; mice: n = 4) or increasing concentrations of
U46619 (10–500 nmol/L; rats: n = 6). When a stable ten-
sion was achived (~3 min) ACh (10 µmol/L) was added
to the chamber. For each vasoconstrictor concentration
the reduction in tension in response to ACh was assessed.
Renal EDH in normo- and hypertensive rats
in vivo
Rats were surgically prepared as previously described
(Frandsen et al., 2016). Briefly, rats were anesthetized
with 8% sevoflurane. In the left jugular vein, two cathe-
ters were inserted for continuous infusion of a muscle
relaxant, cisatracurium (0.6 mg/mL), and isotonic saline
(both 1.2 mL/h). The catheters were also used for i.v.
administration of a nonselective inhibitor of COX 1 and
2, Indomethacin (2 mg/mL, 144 µL/min for 5 min) and
an inhibitor of NO synthesis, L-NAME (2.5 mg/mL,
20 µL/min for 30 min). A catheter filled with heparinized
saline was inserted in the right carotid artery for continu-
ous monitoring of the arterial blood pressure. The trachea
was intubated and the rat was moved to a thermostati-
cally controlled heating plate that maintained body tem-
perature at ~37°C and was connected to a respirator
(~65 breaths/min; tidal volume 8 mL/kg). Incisions were
made to expose the renal and the femoral artery. In order
to infuse drugs into the left renal artery, a catheter (PE-
10) was inserted in the left femoral artery, from where it
was advanced into the renal artery. An ultrasonic flow
probe (Transonic, lPR) was placed around the left renal
artery to allow continuous monitoring of RBF. The left
ureter was catheterized (PE-10 connected to PE-50) to
ensure free urine flow. After the surgical procedure was
completed, the rats recovered for ~30 min before the
experimental protocol was initiated.
Experimental protocols
Reduced vasoconstriction
Isotonic saline was infused for 5 min (144 µL/min) into
the renal artery to obtain baseline RBF and accommodate
to intrarenal infusions. Hereafter ACh (0.5 µmol/L) was
infused for 1.5 min. Next, indomethacin and L-NAME
was given intravenously. After 30 min, isotonic saline was
infused intrarenally for 5 min followed by ACh for
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1.5 min. The a1-adrenergic antagonist prazosin (10 µmol/
L) or the phosphodiesterase inhibitor papaverine
(6.25 µmol/L) was then infused for 5 min into the renal
artery followed by ACh for 1.5 min.
Increased vasoconstriction
A 3-min intrarenal saline infusion (144 µL/min) preceded
the 1.5 min ACh infusion. The ACh response was
assessed before and after intrarenal infusion of NE
(0.0279 nmol/L) or Ang II (0.0665 nmol/L). Thereafter,
indomethacin and L-NAME was administrated as
described above and the protocol was repeated.
Drug concentrations
The drug concentration of the intrarenal infusions repre-
sents the estimated plasma concentration, at an estimated
renal plasma flow (RPF) of 3 mL/min and an infusion
rate of 144 µL/min. The concentrations of prazosin
(10 µmol/L), papaverine (6.25 µmol/L), NE
(0.0279 nmol/L) and Ang II (0.0665 nmol/L) are based
on preliminary experiments. The chosen dosages induced
a slight change in RBF (or MAP) during the 5 or 3 min
pretreatment without changing RBF significantly.
Calculations and statistical analysis
Relative relaxation in isolated interlobar arteries was cal-
culated from the maximal tension elicited by NE or
U46619 and the maximal dilatation elicited by ACh.
Values for MAP and RBF were found as the mean of
the last 30 sec before initiating ACh infusion and the last
30 sec of the ACh infusion. Data are presented as the
means  SEM. Changes in baseline RBF and MAP
(Tables 1–4) were analyzed by One-Way RM ANOVA
using Student–Newman–Keuls (SNK) as post hoc test.
ACh-induced changes in RBF was calculated as %
change from baseline (100%) to account for the different
baselines in SD and SHR and after treatment. Differences
within and between groups (Figs. 2–4) were analyzed
using a two-way ANOVA followed by SNK. P-values less
than 0.05 were considered statistical significant.
Results
EDH in isolated renal interlobar arteries
from rats and mice
The vasoconstrictor response elicited by 10 nmol/L NE in
rat interlobar arteries was very weak (<1 mN) so most
vessels were excluded from the analysis of this NE dose.
In interlobar arteries from mice and rats a decreased
relaxation in response to 10 µmol/L ACh in the presence
of indomethacin and L-NAME was found with increasing
preconstriction from the adrenergic agonist NE
(Fig. 1). In rats, a similar result was seen using the
thromboxane A2 receptor agonist U46619 as a precon-
strictor (Fig. 1).
Renal EDH in normo- and hypertensive rats
in vivo
Baseline values for MAP, RBF, and RVR are shown in
Tables 1–4 for both rat strains. As expected, baseline RBF
was higher and MAP and RVR were lower in SD com-
pared to SHR both before and after inhibition of NO and
prostaglandin production showing that the SHR has
increased renal vascular resistance compared to SD. Treat-
ment with indomethacin and L-NAME (Indo/L-N) signif-
icantly increased MAP and reduced RBF in both strains.
A 5-min intrarenal pretreatment with the a1-adrenergic
antagonist prazosin significantly reduced MAP and RVR
in both SD and SHR but did not affect RBF (Table 1).
Pretreatment with the nonspecific phosphodiesterase inhi-
bitor papaverine increased RBF and reduced RVR signifi-
cantly in SHR but had no effect on MAP in either strain
(Table 2). A 3-minute intrarenal pretreatment with either
NE or Ang II had no significant effect on baseline MAP,
RBF and RVR but tended to decrease RBF in both strains
(Tables 3 and 4).
Data from all rats are combined in Figure 2 to show
the effect of ACh on RBF before and after treatment with
indomethacin and L-NAME. The renal ACh response was
significantly larger in SHR compared to SD. After treat-
ment with L-NAME and indomethacin the EDH-induced
vasodilation was similar between the strains. In both
strains ACh elicited a significantly smaller increase in RBF
after L-NAME/Indo compared to before treatment.
Reduced renal vascular resistance
The renal EDH response was similar in SD and SHR
(Fig. 3A and B). Following pretreatment with the a1-
adrenergic antagonist prazosin the renal EDH response in
SHR increased significantly compared to the response in
SD (Fig. 3A). Interestingly, pretreatment with the non-
specific phosphodiesterase inhibitor papaverine abolished
the renal EDH-response in both rat strains (Fig. 3B).
Increased renal vascular resistance
As observed before the renal EDH response was similar in
SD and SHR (Fig. 4A and B). Following pretreatment
with the adrenergic agonist NE the renal EDH response
increased significantly in SHR (Fig. 4A). Pretreatment
2019 | Vol. 7 | Iss. 15 | e14168
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with Ang II did not affect the EDH response in neither
strain (Fig. 4B).
Discussion
The aim of the present study was to investigate the EDH-
induced vasodilation in the renal microcirculation in
hypertensive and normotensive rats in vivo. Our main
hypothesis was that the increase in RVR seen in hyperten-
sion, possibly induced by the increased blood pressure or
increased sympathetic nerve activity, would reduce
endothelium-dependent vasodilation.
First, we examined the effect of preconstriction in lar-
ger conductance vessels in vitro. Increasing concentrations
of NE or U46619 increased the tension elicited by interlo-
bar arteries in vitro, most likely by an increased VSMC
Table 1. MAP and RBF in SD (n = 8) and SHR (n = 8) before and after treatment with indomethacin and L-NAME (Indo/L-N) and after treat-
ment with the a-adrenergic receptor antagonist prazosin (Indo/L-N/prazo).
Saline Indo/L-N Indo/L-N/prazo
Sprague–Dawley
MAP (mmHg) 97  4 109  8* 87  7*‡
ACh MAP (mmHg) 95  4 109  8† 86  7‡
RBF (mL/min) 6.9  0.4 4.6  0.4† 4.7  0.5†
ACh RBF (mL/min) 8.7  0.5 5.2  0.4† 5.2  0.5†
RVR (mmHg/mL/min) 14.5  1.1 21.4  2.9† 19.7  2.6*‡
ACh RVR (mmHg/mL/min) 11.4  1.0 18.2  2.8† 17.6  2.4†‡
SHR
MAP (mmHg) 138  4 183  6† 163  4†‡
ACh MAP (mmHg) 131  4 182  6† 158  5†‡
RBF (mL/min) 5.1  0.2 2.7  0.3† 2.6  0.2†
ACh RBF (mL/min) 7.7  0.6 3.0  0.3† 3.5  0.4†
RVR (mmHg/mL/min) 27.2  1.2 72.9  6.8† 65.3  5.2†
ACh RVR (mmHg/mL/min) 17.9  1.4 66.6  7.3† 49.0  5.7†‡
ACh values, values measured after 90 sec ACh treatment.
*P < 0.05 versus saline.
†P < 0.01 versus saline.
‡P < 0.01 versus Indo/L-N.
Table 2. MAP and RBF in SD (n = 8) and SHR (n = 8) before and after treatment with indomethacin and L-NAME (Indo/L-N) and after treat-
ment with the phosphodiesterase inhibitor papaverine (Indo/L-N/papa).
Saline Indo/L-N Indo/L-N/papa
Sprague–Dawley
MAP (mmHg) 106  3 129  6* 128  6*
ACh MAP (mmHg) 105  3 128  5* 128  6*
RBF (mL/min) 8.7  0.5 5.9  0.2* 6.6  0.5*
ACh RBF (mL/min) 10.7  0.6 6.5  0.2* 6.7  0.5*
RVR (mmHg/mL/min) 12.4  0.6 22.1  1.1* 20.6  2.1*
ACh RVR (mmHg/mL/min) 9.9  0.4 19.9  1.1* 20.2  2.2*
SHR
MAP (mmHg) 141  6 188  7* 186  7*
ACh MAP (mmHg) 136  6 186  6* 184  7*
RBF (mL/min) 6.3  0.6 3.4  0.4* 4.2  0.4*†
ACh RBF (mL/min) 9.1  0.6 3.8  0.4* 4.1  0.4*
RVR (mmHg/mL/min) 24.8  3.6 64.1  11.3* 48.5  6.9*†
ACh RVR (mmHg/mL/min) 15.7  1.8 55.6  9.2* 48.3  5.9*
ACh values, values measured after 90-sec ACh treatment.
*P < 0.01 versus saline.
†P < 0.01 versus Indo/L-N.
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membrane depolarization (Salomonsson and Arendshorst,
1999). This significantly reduced renal EDH-induced
vasodilation in vitro. However, as similar results were
obtained using the TxA2 analouge U46619, these results
indicate that it is the increased tension per se and not an
increased activation of adrenergic receptors that reduces
EDH-induced vasodilation under isometric conditions.
We have previously shown that EDH-induced vasodila-
tion in interlobar arteries is initiated by activation of
endothelial IKCa and SKCa channels releasing K
+ to acti-
vate Kir channels and Na
+/K+-APTases on the vascular
smooth muscle cell (Rasmussen et al., 2016; Brasen et al.,
2018). However, if the concentration of K+ surrounding
the VSMC increases, the Kir channels and Na
+/K+-
APTases become saturated and EDH-induced vasodilation
decreases (Edwards and Weston, 2004) as also seen in the
present study.
In isolated renal arteries from 8-week-old SHR the
EDH-induced vasodilation is increased compared to age-
matched WKY (Bussemaker et al., 2003). However, at the
age of 22 months the renal EDH response in SHR is abol-
ished (Bussemaker et al., 2003) indicating that with
Table 3. MAP and RBF in SD (n = 5) and SHR (n = 8) before and after treatment with indomethacin and L-NAME (Indo/L-N) and after treat-
ment with the adrenergic receptor agonist NE (Indo/L-N/NE).
Saline Indo/L-N Indo/L-N/NE
Sprague–Dawley
MAP (mmHg) 110  3 147  3* 147  2*
ACh MAP (mmHg) 109  3 148  3* 148  3*
RBF (mL/min) 7.9  0.3 4.4  0.5* 4.0  0.4*
ACh RBF (mL/min) 10.0  0.6 4.8  0.5* 4.7  0.4*
RVR (mmHg /mL/min) 14.0  0.7 36.2  5.5* 39.7  5.1*
ACh RVR (mmHg /mL/min) 10.9  0.4 33.4  4.7* 32.8  3.6*
SHR
MAP (mmHg) 153  6 183  6* 180  8*
ACh MAP (mmHg) 147  6 182  7* 177  8*
RBF (mL/min) 6.8  0.8 3.7  0.5* 3.2  0.4*
ACh RBF (mL/min) 9.0  0.8 4.2  0.4* 4.1  0.5*
RVR (mmHg /mL/min) 24.3  2.7 56.8  8.3* 63.7  8.5*
ACh RVR (mmHg /mL/min) 17.1  1.5 46.3  4.0* 47.1  5.4*
ACh values, values measured after 90-sec ACh treatment.
*P < 0.01 versus saline.
Table 4. MAP and RBF in SD (n = 6) and SHR (n = 6) before and after treatment with indomethacin and L-NAME (Indo/L-N) and after treat-
ment with angiotensin II (Indo/L-N/AngII).
Saline Indo/L-N Indo/L-N/AngII
Sprague–Dawley
MAP (mmHg) 97  2 125  7* 125  8*
ACh MAP (mmHg) 96  3 125  7* 124  8*
RBF (mL/min) 7.5  0.8 5.8  0.6* 5.6  0.7*
ACh RBF (mL/min) 10.1  1.2 6.7  0.7* 6.7  0.8*
RVR (mmHg/mL/min) 13.9  1.7 23.6  3.7* 25.0  4.7*
ACh RVR (mmHg/mL/min) 10.5  1.5 20.5  3.5* 20.8  4.0*
SHR
MAP (mmHg) 171  6 202  2* 195  3*
ACh MAP (mmHg) 166  6 200  3* 194  3*
RBF (mL/min) 6.6  0.4 3.4  0.5* 3.0  0.4*
ACh RBF (mL/min) 8.4  0.4 4.0  0.5* 3.7  0.4*
RVR (mmHg /mL/min) 26.7  1.9 73.0  17.3* 72.9  11.0*
ACh RVR (mmHg /mL/min) 19.8  0.9 56.6  9.8* 57.1  7.6*
ACh values, values measured after 90-sec ACh treatment.
*P < 0.01 versus saline.
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increasing age and blood pressure EDH diminishes. Mea-
surements of resting membrane potentials from VSMC
from renal arteries show a significant depolarization at
increasing age in SHR but not in WKY (Bussemaker
et al., 2003). The hyperpolarizing effect of renal EDH on
VSMC is also significantly decreased in 22-month-old
SHR. At 8 months of age the renal EDH-induced vasodi-
lation measured in the renal artery is significantly reduced
in SHR compared to WKY (Michel et al., 2008). In 26-
week-old SHR EDH-induced vasodilation measured at
increasing doses of ACh in renal segmental arteries is
right-shifted compared to the curve measured in renal
arteries from WKY but the maximum vasodilation at 1-
µmol/L ACh is identical (Dohi et al., 1996). Thus, is
seems as if renal EDH is present in younger SHR but
diminishes at increasing age and blood pressure.
The results from the isolated interlobar arteries are
based on isometric constriction. It has been reported that
EDH-induced vasodilation behaves differently depending
on the experimental set-up. In isolated A. gracilis from
mice ACh-induced vasodilation during isometric condi-
tions was significantly smaller after inhibition of L-NAME
and indomethacin compared to before (Boettcher and
Wit, 2011). However, during isobaric conditions and
in vivo the ACh-induced vasodilation before and after
inhibition of eNOS and COX was similar indicating that
EDH is the primary endothelial vasodilator during these
conditions. This is in contrast to the renal EDH where
inhibition of eNOS and COX significantly reduced the
Ach-induced vasodilation both in vitro and in vivo
(Majid and Navar, 1992; Dautzenberg and Just, 2013;
Rasmussen et al., 2016). The renal in vitro results are
from larger conductance vessels whereas the in vivo mea-
surements show the integrated responses from small resis-
tance vessels. EDH has been shown to be more
pronounced in smaller conductance vessels compared to
larger conductance vessels (Boettcher and Wit, 2011)
which may further complicate the picture.
Secondly, we characterized EDH in SD and SHR
in vivo, and studied the effects of sympathetic activity
and increased vascular resistance on EDH. In the present
study we found that in anesthetized normotensive SD rats
and SHR increases in RBF were elicited by intrarenal
infusions of 0.5-µmol/L ACh. In SHR the renal ACh-in-
duced vasodilation was significantly larger compared to
the normotensive rats. This suggests that at 12 weeks of
age renal endothelial dysfunction is not prominent in
SHR. After inhibition of NO and PGI2 production the
Figure 1. Increased preconstriction using NE or U46619 reduced the renal vasodilation elicited by 10-µmol/L ACh after treatment with L-NAME
and indomethacin. Rat vessels responded poorly to the lowest agonist concentration (n = 3 for NE and n = 2 for U46619). The EDH response
was not different between species (mice; n = 4, rats; n = 10). *P < 0.05 versus 50 nmol/L.
Figure 2. Increases in RBF compared to baseline during intrarenal
infusion of ACh in SD (n = 27) and SHR (n = 30). The increase in
RBF was significantly higher in SHR. After treatment with L-NAME
and indomethacin (L/I) the response was significantly lowered in
both rat strains. The EDH response was not different between
strains. * P < 0.01 versus SD; †P < 0.01 versus NaCl.
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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ACh-induced renal vasodilation was similar between the
two strains and significantly smaller than before inhibi-
tion indicating an increased importance of NO in 12-
week-old SHR. This corresponds well with our observed
increased effect of L-NAME on RVR in SHR compared to
SD (Tables 1–4). In Wistar rats the renal EDH response
to bolus infusion of ACh has been investigated in vivo
(Vriese et al., 2002; Edgley et al., 2008). Here it was also
found that in normotensive rats in vivo, inhibition of
eNOS and COX significantly reduces the vasodilatory
response to ACh. This is in contrast to the above men-
tioned results from Boettcher et al. (Boettcher and Wit,
2011) but could possibly be explained by the use of dif-
ferent species and different vascular beds being investi-
gated.
To test the hypothesis that an increased renal vascular
resistance also would affect the EDH-induced renal
vasodilation in vivo we treated the rats with vasodilators
(prazosin and papaverine) and vasoconstrictors (NE and
Ang II). Papaverine and Ang II were chosen to reduce
and increase RVR by other means than through a-adren-
ergic receptors. Treatment with the a1-adrenergic antago-
nist prazosin reduced MAP compared to L-NAME/
indomethacin but did not significantly increase RBF.
However, the renal vascular resistance decreased signifi-
cantly in both strains. Assessment of the EDH-induced
renal vasodilation showed that prazosin significantly
increased the EDH response in SHR but not in SD. These
results seem to correspond to previous findings showing
that VSMC from SHR are more depolarized and constrict
more strongly to NE (Hermsmeyer, 1976). Inhibition of
the increased vasoconstriction from NE using prazosin
could reduce the depolarization of the VSMC in SHR.
Thus, it may be easier to induce an EDH-induced vasodi-
lation after prazosin in SHR.
Figure 3. Increases in RBF during intrarenal infusion of ACh
compared to baseline. All experiments were done in the presence
of L-NAME and indomethacin (L/I). After pretreatment with
prazosin the response was significantly increased in SHR (n = 8) but
not in SD (n = 8) (A). After pretreatment with papaverine the
response was significantly reduced in both strains (SD; n = 8, SHR
n = 8) (B). *P < 0.01 versus SD; † P < 0.01 versus L/I.
Figure 4. Increases in RBF during intrarenal infusion of ACh
compared to baseline. All experiments were performed in the
presence of L-NAME and indomethacin (L/I). After pretreatment
with NE the renal EDH response increased in SHR (n = 8) but not in
SD (n = 5) (A). After pretreatment with Ang II the EDH response
was unchanged in both strains (SD; n = 6, SHR n = 6) (B).
*P < 0.05 versus L/I.
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When reducing renal vascular resistance using papaver-
ine we found that the EDH-induced renal vasodilation
was absent in both strains. Papaverine did not change
MAP in either strain and only increased RBF significantly
in SHR. Interestingly, the use of papaverine seemingly
abolished the ability of EDH to dilate the renal vascula-
ture in both strains. This could suggest that the renal vas-
culature is not able to dilate any further but the dose of
papaverine used in our study only increased RBF slightly
suggesting that the renal vasculature is not maximally
dilated. In dogs papaverine completely abolished renal
autoregulation in contrast to nitro-compounds such as
sodium nitroprusside (Ogawa and Ono, 1986) which
could suggest that the renal vasculature loses the ability
to regulate tone after papaverine treatment. Papaverine
increases cAMP and cGMP in VSMC from renal arteries
(Karsten et al., 2003) leading to decreases in intracellular
[Ca2+] (Gagnon et al., 1980). However, in rabbit iliac
arteries the EDH response is potentiated by increasing
cAMP in vascular smooth muscle cells (Griffith et al.,
2002). Another explanation could therefore be that the
concentration of cAMP in VSMC is already maximal and
no further increase is generated when ACh is added thus
eliminating the EDH response. It has also been suggested
that the renal EDH is either K+ released from EC (Edgley
et al., 2008; Rasmussen et al., 2016) or transfer of the
hyperpolarization through gap junctions (Vriese et al.,
2002). Inhibition of renal gap junctions did not affect the
renal vasodilation induced by papaverine suggesting that
there is no interaction between papaverine and gap junc-
tions in the renal vasculature (Vriese et al., 2002). How-
ever, several K+ channels are activated by protein kinase
A and G (Salomonsson et al., 2017). Possibly, the release
of K+ from VSMC is high enough to saturate the Kir
channels and Na+/K+-ATPases and prevent a further
hyperpolarization in this setting.
Pretreatment with the vasoconstrictors NE and Ang II
induced a slight reduction in RBF in both strains, but the
effect on RVR was not significant in comparison to the
RVR measured after L-NAME/indomethacin treatment.
However, due to the relative long half-life of L-NAME in
plasma (Conner et al., 2000) the experiments using pre-
treatment with vasodilators or inhibitors were always car-
ried out as the last experiment. As the sevoflurane
anesthesia will slowly reduce MAP and RBF it is possible
that the effect of the pretreatment is underestimated in
our experiments. When comparing the RVR found after
NE treatment in SD (39.7-mmHg/mL/min) with the RVR
measured directly before NE infusion (35.7-mmHg/mL/
min) the effect is significant.
The pretreatment with NE did however increase the
EDH-induced vasodilation observed in SHR which is the
same effect as seen when reducing RVR. Considering that
the VSMC from SHR are proposed to be more sensitive
to NE (Mulvany et al., 1980), NE would theoretically
induce a stronger depolarization and decrease the EDH-
induced vasodilation. The present increase in renal EDH-
induced vasodilation in vivo is thus hard to explain.
However, vasoconstriction elicited by an a1-adrenergic
receptor agonist (phenylephrine) is time dependently
reduced in rat mesenteric arteries (Jin et al., 2011). This
reduction is abolished by removal of the endothelium but
not by treatment with indomethacin and L-NAME indi-
cating that a1-adrenergic stimulation increases EDH pro-
duction. Possibly the increased depolarization and
contraction observed in VSMC from SHR in response to
NE could be caused by an increased expression of a1-
adrenergic receptors in SHR. Studies show than in VSMC
from aorta there seems to be an increased expression of
a1A- and a1B-receptors compared to WKY but this was
not found in carotid arteries (Edith-Rodriguez et al.,
2013). Increased function of a1A- and a1D-receptors in
the hindlimb vascular bed of SHR has also been found
(Ye and Colquhoun, 1998).
In conclusion, we found that the renal EDH response
measured in young SHR in vivo is not reduced com-
pared to normotensive rats. Importantly, at this age renal
endothelial dysfunction does not seem to be prevalent in
SHR even though blood pressure is significantly
increased and renal blood flow is significantly lower. This
is in contrast to the EDH response found in isolated
renal arteries from 8-week-old SHR where the EDH
response was higher than in normotensive WKY. At
14 weeks of age the EDH-induced vasodilation in affer-
ent arterioles was significantly reduced. Possibly, the
EDH response measured in our experiments at 12 weeks
is in the transition from an increased to a decreased
renal EDH response. The changes induced in RVR did
not affect the renal EDH in the predicted direction. a1-
receptor inhibition with prazosin to reduce RVR
enhanced EDH in SHR but not in SD in vivo. a1-recep-
tor activation with NE causing an increased RVR also
enhanced EDH in SHR in vivo. Thus, both increases and
decreases in RVR elicited a larger EDH-induced vasodila-
tion in SHR and had no effect in normotensive rats.
Possibly, the induced changes are buffered in the in vivo
setting but not in vitro.
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